The Year in Coronary Artery Disease  by Achenbach, Stephan et al.
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echnology in cardiovascular imaging continues to evolve rapidly. Along with new technology, new
maging approaches are continuously being developed and evaluated in various clinical settings. The
orkupofpatientswith coronary arterydisease (CAD) is oneof themajor areas inwhich imaging is applied.
ome of the most important aspects include diagnosing CAD through direct coronary visualization or
maging of ischemia; assessing left ventricular function, scar, and viability; and providing prognostic
nformation both in patients with known CAD and in asymptomatic individuals at risk for disease. This
rticle will outline some of the recent developments in the field of echocardiography, nuclear imaging,
ardiac magnetic resonance (CMR), and computed tomography (CT) as they pertain to CAD. (J Am Coll
ardiol Img 2009;2:774–86) © 2009 by the American College of Cardiology Foundationt
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mprovements in imaging technology comprise
dvances in hardware that result in better
erformance and new pharmacological agents,
s well as new software approaches to image
rocessing and analysis. In echocardiography,
utomated methods for quantitation of re-
ional function with speckle tracking of re-
ected ultrasound waves and velocity vector
maging, a feature tracking technique, were
alidated in animal models (1,2). Myocardial
train and strain rate derived with these meth-
ds correlated well with independent standards
f regional function during ischemia-reperfusion
r with dobutamine stimulation with increasing
egrees of coronary stenosis (1,2). These meth-
ds allow quantitative and objective interpreta-
rom the *Department of Cardiology, University of Erlangen, E
edicine, University of Maryland School of Medicine, Baltimore,
niversity of Virginia Health System, Charlottesville, Virginia; a
eBakey Heart and Vascular Center, Houston, Texas. Dr. Achenb
rom Bundesministerium für Bildung und Forschung (BMBF), Boanuscript received January 6, 2009, accepted January 16, 2009.ion of regional function that can be used for
etection of CAD in rest and stress studies or
o assess the burden of ischemia during acute
oronary syndromes.
New hardware was seen in nuclear imaging. A
igh-speed, myocardial perfusion single-photon
mission computed tomography (SPECT) cam-
ra has been introduced (Fig. 1) (3). It uses a
ank of independently controlled detector col-
mns with large-hole tungsten collimators and
ultiple cadmium zinc telluride crystal arrays. In
4 patients undergoing Tc-99m sestamibi myo-
ardial perfusion imaging, stress and rest acquisi-
ion times were 16 and 11 min for conventional
PECT but only 4 and 2 min for high-speed
PECT, respectively. With high-speed SPECT,
yocardial count rates were 7- to 8-fold higher
han in conventional SPECT, with 97% of im-
gen, Germany; †Departments of Radiology and
yland; ‡Departments of Medicine and Radiology,
he §Department of Cardiology, The Methodist
is partly supported by Grant BMBF 01 EV 0708,
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775ges graded as “good” or better. Moreover, the level of
iagnostic confidence was equal for both SPECT
ystems, and myocardial perfusion uptake scores cor-
elated closely (r 0.93) (3). If these initial results are
onfirmed in a larger patient population using quan-
itative analysis, high-speed SPECT systems might
ave the way for new radiotracers and pharmacologic
tressors in the future.
In addition, a new A2A-selective adenosine re-
eptor agonist, regadenoson, was introduced for
harmacologic myocardial perfusion stress testing
ith SPECT (4). The commonly used pharmaco-
ogic vasodilators adenosine and dipyridamole stim-
late all 4 adenosine receptor subtypes. Stimulation
f the A2A receptor subtype causes the differential
oronary arterial dilation required for myocardial
erfusion SPECT imaging. Regadenoson induces a
- to 3-fold increase in myocardial blood flow for 3
o 4 min. In 2,015 patients from Phase 3 trials,
oninferiority of regadenoson for the detection of
yocardial ischemia was demonstrated as compared
ith adenosine (4). Regadenoson caused more
eadache and gastrointestinal discomfort but had a
ower combined symptom score and caused less
hest pain, flushing, and throat/neck/jaw pain.
CT technology continues to undergo rapid tech-
ological evolution. Despite tremendous progress
Figure 1. Myocardial Perfusion Imaging by Conventional and H
Conventional single-photon emission computed tomography (SPEC
ischemia of the left anterior descending coronary artery and ischem
terized by better resolution with clearer edge deﬁnition and thinne
speed SPECT images. Reproduced with permission from Sharir et alade in the past years, spatial and especially tem- aoral resolution continue to pose a challenge when
oronary artery visualization is attempted. After
ual source CT was introduced in 2006 with a high
iagnostic accuracy for coronary stenosis detection,
reserved at high heart rates (5,6), 2 manufacturers
ntroduced CT systems that have substantially
ider detectors and allow simultaneous sampling of
56 or even 320 slices (7). Therefore, it is theoret-
cally possible to acquire all necessary data in a
ingle rotation of the gantry, in 1 single cardiac
ycle, thus avoiding misregistration or misalign-
ent artifacts that can occur with more narrow
etectors. For higher heart rates, data sampling
ight extend over 2 or 3 consecutive heartbeats to
llow for multi-segment reconstruction (7).
Another area of intense interest was the radiation
xposure associated with CT imaging in general
nd cardiac CT imaging in particular (8,9) and
ewer approaches to lower the radiation exposure
uring coronary computed tomography angiogra-
hy (CTA). One possible advance is the reduction
f tube current to 100 kV (as opposed to the
tandard 120 kV), which can lower radiation expo-
ure by 30% to 40% while maintaining diagnostic
ccuracy in nonobese patients (10). Another even
ore effective approach is to change the acquisition
ode from retrospectively gated “spiral” or “helical”
Speed SPECT in a Patient With Previous Myocardial Infarction
op) and high-speed SPECT (bottom) images showing infarct and
f the right coronary artery. High-speed SPECT images are charac-
ntricular walls. The inferior ischemia is better seen with high-
.igh-
T) (t
ia o
r vecquisition to “prospectively triggered” or “step-
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776nd-shoot” protocols. Several studies have reported
ery low effective radiation doses for such protocols,
anging from 1.2 to 4.3 mSv and a reduction of
adiation exposure by 77% to 83% compared with
onventional protocols (Fig. 2) (11–17). Prospective
riggering seems to be a valuable alternative to
onventional spiral image acquisition approach for
oronary CTA, especially in patients with a low
eart rate (below 60 to 65 beats/min) (18).
New scanning sequences were introduced for 3-T
ardiac magnetic resonance (CMR) imaging. A
ew sequence for myocardial perfusion imaging
ith highly parallel imaging in a 3-T magnet,
hich was validated in 14 volunteers and 37 pa-
ients, allowed for high spatial resolution and
howed similar diagnostic accuracy for detection of
AD but with improved image quality and reduced
rtefacts compared with 1.5-T (19).
iagnosis of CAD
ne of the major goals of imaging in the context of
AD is the identification of patients, vessels, and
tenosed coronary segments that lead to ischemia.
asically, 2 approaches are possible: direct visual-
zation of the coronary arteries (e.g., by cardiac CT)
r demonstration of downstream effects caused by
oronary stenoses, such as wall motion abnormali-
ies or impaired myocardial perfusion (by echocar-
iography, nuclear imaging, and CMR). In echo-
ardiography, advances have been made both for
all motion and perfusion analysis. The OPTI-
ZE (A Randomized Cross-Over Study for Eval-
ation of the Effect of Image Optimization With
ontrast on the Diagnostic Accuracy of Dobut-
mine Echocardiography in Coronary Artery Dis-
ase) trial evaluated endocardial border image opti-
ization with contrast on the diagnostic accuracy of
obutamine stress echocardiography (DSE) in the
etection of CAD (20). In 101 patients who un-
erwent 2 DSE studies, 1 without and 1 with
ontrast enhancement with perflutren lipid micro-
pheres (Definity, Bristol-Myers Squibb, Billerica,
assachusetts), contrast improved the percent of
egments adequately visualized at baseline (from 72
24% to 95 8%) and even more so at peak stress
67  28% to 96  7%). Interpretation of wall
otion with high confidence also increased from
6% to 74% with the use of contrast. As the extent
f endocardial visualization and confidence of in-
erpretation decreased in nonenhanced studies, an
ncreased impact of contrast on DSE accuracy
ompared with angiography was observed.Figure 2. Coronary Computed Tomography Angiography With
Low Radiation Exposure
Curved multiplanar reconstructions of the right coronary artery
(A), left anterior descending coronary artery (B), and left circum-
ﬂex coronary artery (C) obtained by contrast-enhanced dual
source computed tomography. Imaging was performed with
prospective triggering (thus, X-rays were emitted only during 1
pre-speciﬁed time instant in diastole) and with a tube voltage of
100 kVp (instead of the more frequently used 120 kVp). Esti-
mated effective radiation dose for this scan was 1.8 mSv.
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777In addition to wall motion analysis, the assess-
ent of myocardial perfusion using echo contrast
gents further enhances the detection of patients
ith CAD compared with assessment of wall mo-
ion alone. In a study involving 50 patients, real-
ime myocardial perfusion with contrast was per-
ormed during DSE. Subendocardial perfusion
bnormalities that corresponded to myocardial isch-
mia were observed in areas where wall thickening
as still preserved (21) and could further enhance the
ccuracy of DSE for the detection of CAD (Fig. 3).
In October 2007, the U.S. Food and Drug
dministration issued a Boxed Warning regarding
he safety of echo contrast agents, particularly in
emodynamically unstable patients. Since then,
everal safety studies published in 2008, including a
ulticenter retrospective study sponsored by the
merican Society of Echocardiography, have be-
ome available (22–25) and helped reverse the
ewly stated contraindications in May 2008. Thus,
eart failure, acute coronary syndromes, arrhyth-
ias, and pulmonary disease no longer constitute
ontraindications to the use of microbubble contrast
gents; high-risk patients with pulmonary hyper-
ension or unstable cardiopulmonary conditions
Figure 3. Echocardiographic Measurement of Subendocardial W
Apical 4-chamber view of real-time myocardial contrast echocardiog
with signiﬁcant left anterior descending coronary artery disease dur
(ED) and end-systolic (ES) wall thickness (WT) for transmural wall th
(MCR) images (the ﬁrst cardiac cycle after the high mechanical inde
der (blue arrows) delineated with left ventricular cavity contrast an
was measurable only if a subendocardial perfusion defect was pres
els). Reproduced with permission from Xie et al. (21).till need to be monitored for 30 min after
dministration.
Beyond perfusion, nuclear imaging allows assess-
ent of cardiac metabolism. Increased glucose me-
abolism is a hallmark of reversibly ischemic myo-
ardium. In 24 patients with strong clinical
uspicion of CAD, simultaneous dual-isotope in-
ection of sestamibi and fluorodeoxyglucose (FDG)
t peak exercise and rest was performed (26). The
etabolic signal with FDG was more sensitive than
estamibi myocardial perfusion SPECT for detect-
ng myocardial ischemia. Among patients with
bnormal FDG uptake at peak exercise, 47% exhib-
ted residual abnormal FDG uptake at rest, 24 h
fter the exercise-induced ischemia, consistent with
he concept of “ischemic memory,” which provides
he potential for diagnosing myocardial ischemia in
he acute care setting. Thus, metabolism plays a
ritical role in sustaining myocellular viability by
dapting quickly to the ischemic injury response but
ith recovery of metabolism lagging behind perfu-
ion for 24 h or more (27).
For the detection of CAD, CT relies almost
xclusively on the direct visualization of the coro-
ary arteries. During the past year, several analyses
hickening With Myocardial Contrast
hy with contrast pulse sequencing was obtained from a patient
dobutamine stress. Note the perfusion defect. The end-diastolic
ning are measured on the pre-myocardial contrast replenishment
pulse) (left panels) as the distance between the endocardial bor-
e epicardial border (blue arrows). Subendocardial wall thickening
(red arrows) during the replenishment period (MCR) (right pan-all T
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778ave clearly demonstrated the superiority of 64-slice
T over previous technology (28–34) for the de-
ection of coronary artery stenoses. Several meta-
nalyses demonstrated high sensitivities (96% to
9%) and (93% to 94%) for CAD in individuals
ith at least 1 coronary artery stenosis (Table 1).
or the detection of in-stent stenoses, 2 additional
eta-analyses demonstrated insufficient sensitivity
f coronary CTA (82% and 84%) (35,36).
Three large multicenter trials concerning the
ccuracy of 64-slice CT for stenosis detection have
een published (37–39) (Table 2). The ACCU-
ACY (Assessment by Coronary Computed To-
ographic Angiography of Individuals Undergoing
nvasive Coronary Angiography) trial studied 230
atients with suspected CAD (37). Prevalence of
isease was 25%, and per-patient sensitivity and
pecificity for detecting individuals with at least 1
tenosis 50% was 95% and 83%, respectively. The
egative predictive value was 99%, but the positive
redictive value was only 64%. The Core64 (Cor-
nary Artery Evaluation Using 64-Row Multide-
ector Computed Tomography Angiography) trial
tudied a group of 291 patients with a different
omposition. Prevalence of obstructive disease was
6%, and 30% of the patients had previous myo-
es of the Accuracy of Contrast-Enhanced 64-Slice Coronary Comp
n Sensitivity
) Per-patient 363 99% (97%–100%) 9
Per-segment 5,030 93% (88%–97%) 9
Per-patient 875 98% (96%–99%) 9
Per-segment 17,695 86% (85%–87%) 9
Per-patient 695 97% (95%–98%) 9
Per-segment 10,388 88% (86%–89%) 9
2) Per-patient — 96% (93%–100%) 9
Per-segment — 91% (86%–97%) 9
Per-patient 1,286 99% (97%–99%) 8
Per-segment 14,199 90% (85%–94%) 9
le segments were excluded from analysis.
tudies That Addressed the Accuracy of Coronary Artery Stenosis
aphy
Number of
Sites
Number of
Patients
Prevalence of
Obstructive
CAD* Sensitivi
16 230 25% 95% (85%–9
9 291 56% 85% (79%–9
3 360 68% 99% (98%–1
nosis 50% diameter reduction.
isease.ardial infarction (MI) or coronary revascularization
38). Per-patient sensitivity was 85% and specificity
as 90% (negative predictive value 83%, and posi-
ive predictive value 91%). Finally, Meijboom et al.
39) published a trial performed at 3 different sites,
hich enrolled 360 patients with stable (n  233)
r unstable symptoms (n  127). Prevalence of
bstructive disease was 68%, and 64-slice CT had a
ensitivity of 99% but only 64% specificity for the
dentification of individuals with at least 1 coronary
rtery stenosis (Fig. 4). The results of these trials
rovide further evidence that CTA can be highly
eliable to rule out the presence of CAD but that its
erformance strongly depends on the type of pa-
ients evaluated.
In a study of 80 patients it was shown that
oronary CTA can identify “high-risk” coronary
natomy (40). Several recent studies studied the
ffect of CTA on downstream testing and demon-
trated that a coronary CTA negative for stenoses
ndicates a very favorable clinical outcome (41–43).
in et al. (44) identified 1,647 individuals in whom
oronary CTA was performed without previously
nown CAD. He showed that the rate of down-
tream catheterization was substantially lower if CT
as performed than in patients in whom stress
d Tomography Angiography to Identify Coronary Artery
eciﬁcity
Negative Predictive
Value
Positive Predictive
Value
(89%–98%) — —
(96%–97%) — —
(88%–94%) 97% 94%
(96%–97%) 97% 83%
(86%–93%) 96% (92%–98%) 93% (91%–96%)
(96%–97%) 98% (98%–98%) 79% (77%–81%)
(85%–96%) 96% (91%–100%) 93% (87%–98%)
(96%–97%) 98% (96%–100%) 78% (69%–87%)
(83%–94%) 100% (86%–100%) 93% (64%–100%)
(95%–98%) 99% (95%–100%) 76% (44%–93%)
tection by Contrast-Enhanced 64-Slice Coronary Computed
Speciﬁcity
Negative
Predictive
Value
Positive
Predictive
Value
83% (76%–88%) 99% (96%–100%) 64% (53%–75%)
90% (83%–94%) 83% (75%–89%) 91% (86%–95%)
) 64% (55%–73%) 97% (94%–100%) 86% (82%–90%)Table 1. Meta-Analys ute
Stenoses
Author (Ref. #) Sp
Vanhoenacker et al. (29 3%
6%
Abdulla et al. (30) 1%
6%
Hamon et al. (31) 0%
6%
Gopalakrishnan et al. (3 1%
6%
Mowatt et al. (33) 9%
7%Table 2. Multicenter S De
Tomography Angiogr
Author (Ref. #) ty
Budoff et al. (37) 9%)
Miller et al. (38) 0%)
Meijboom et al. (39) 00%
*Presence of at least 1 ste
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779yocardial perfusion imaging had been performed
1.7% vs. 9.6%). The rate of downstream revascu-
arization was 0.2% versus 0.8%, but outcomes were
o worse for CTA as the initial test, with a lower
ate of hospital stay for CAD (0.7% vs. 1.1%) and a
ower rate of angina (4.3% vs. 6.4%).
Although CMR also has the potential to visual-
ze the coronary arteries, image quality is often
mpaired, and the analysis of perfusion, wall mo-
ion, or infarct scars has higher accuracy when
atients are evaluated regarding the presence of
AD. In a study of 54 patients scheduled for
nvasive coronary angiography and studied with a
ombined magnetic resonance technique of coro-
ary imaging, first-pass perfusion, and late gadolin-
um enhancement (LGE), coronary magnetic reso-
ance angiography added little value (sensitivity
1%, specificity 46%), whereas perfusion alone yielded
he best results (sensitivity 87%, specificity 88%) (45).
n fact, a multicenter study comparing SPECT with
ontrast-enhanced myocardial perfusion CMR in 234
atients demonstrated better overall diagnostic accu-
acy for CMR (46). In a study performed at 3-T with
asodilator stress perfusion imaging in 101 patients
ith high prevalence of CAD (69%), sensitivity was
0%, specificity 71%, and overall accuracy was 84% for
he detection of high-grade coronary stenoses (47).
vidence of myocardial ischemia without obstructive
picardial disease was demonstrated in 56% of 18
yndrome X patients with vasodilator stress perfusion
MR. The CMR findings correlated significantly to
easures of coronary flow reserve in the left anterior
escending coronary artery territory (r  0.45, p 
.019) (48).
CMR has the unique potential of visualizing
Figure 4. CTA With a 64-Slice Scanner in a Patient With Signiﬁc
A thick maximum-intensity projected coronary computed tomograp
onary artery (RCA). A curved multiplanar reformatted image (B) disc
stenosis of intermediate degree further distally (arrowheads). Both
Reproduced with permission from Meijboom et al. (39).yocardial edema. In 62 individuals presenting to vhe emergency department with chest pain, a new
lgorithm incorporating T2-weighted imaging for
dentification of myocardial edema improved the
verall accuracy of standard CMR approaches with
rst-pass contrast-enhanced perfusion, LGE, and
ine-functional imaging from 84% to 93% (49).
maging of Viability
maging of myocardial viability has important im-
lications for making treatment decisions. This has
learly been shown in a noteworthy study of 70
onsecutive patients with left ventricular (LV) an-
urysm who underwent nuclear imaging by 99mTc-
estamibi SPECT and 18F-FDG positron emission
omography (PET) (50) and were followed for a
edian period of 6.8 years. Patients were classified
nto 4 groups by aneurysmal viability and by treat-
ent strategy (medical or surgical). The annual
ardiac mortality rate in patients with a viable
neurysm treated medically (n  10) was signifi-
antly higher than that in patients with a viable
neurysm treated surgically (n  23) (11.6% vs.
.5%, p  0.0001) and was also significantly higher
han that in patients with a nonviable aneurysm
reated medically (n  14, p  0.05) or surgically
n  23, p  0.001). Multivariate analysis showed
hat the aneurysmal mismatch score (p  0.003)
nd surgical therapy (p  0.001) were independent
redictors of cardiac death. Improvement of LV
unction and symptoms after revascularization (p 
.05) was observed in patients with revasculariza-
ion plus aneurysmectomy and in patients with a
iable aneurysm and revascularization only. The
ndings suggest that the presence of myocardial
Stenoses of the RCA
ngiography (CTA) image (A) shows the anatomy of the right cor-
s a signiﬁcant coronary stenosis (arrows) in the mid RCA and a
ns were corroborated by conventional coronary angiography (C).ant
hy a
lose
lesioiability within an LV aneurysm is a negative
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780ndependent predictor of survival in patients with
schemic cardiomyopathy.
Late enhancement in CMR is frequently used for
iability assessment. Gadoversetamide, a new con-
rast agent, was evaluated for detection of acute and
hronic MI in 566 patients who were randomized
o doses between 0.1 and 0.3 mmol/kg, and a dose
f0.2 mmol/kg was sensitive for scar visualization
51). CMR late enhancement was used in studies to
ssess pharmacologic reduction of infarct size dur-
ng reperfusion of acute MI (52). T2-weighted
maging (which can visualize myocardial edema)
Fig. 5) came to the fore as a method to image the
alvaged area at risk in a study of 92 patients with
eperfused acute MI (53). The area of increased
2-signal was 16% greater than the area of LGE. A
omprehensive study of recovery of regional and
lobal function after acute MI demonstrated that
he presence of microvascular obstruction was the
ost powerful predictor, more powerful than the
ransmural extent of infarction (54). In a different
etting, CMR late enhancement imaging was used
o show that the incidence of new irreversible
yocardial injury/scar was higher in patients with
n-pump beating heart coronary artery bypass graft
urgery than in on-pump conventional coronary
rtery bypass graft surgery in 50 patients with
educed LV function (55).
Similar to CMR, CT allows imaging of function,
rst-pass perfusion, and even late enhancement. In
small series of 21 patients, it was shown that CT
maging—after injection of iodinated contrast
gent—allows identification both of delayed hyper-
nhancement (detectable in 11 of 15 patients as
ompared with CMR) and of microvascular ob-
Figure 5. Visualization of Myocardial Edema in T2-Weighted CM
(Left) T2-weighted cardiac magnetic resonance (CMR) image of a h
cardium. (Right) T2-weighted CMR image of a patient with an acute
apparent by a thickened myocardium with high signal (arrows). Ap
(arrowhead). Reproduced with permission from Friedrich et al. (53).truction, visible through delayed hypoenhance-
ent (56). CT imaging 5 min after contrast injec-
ion provided better image quality than imaging 10
in after injection (57). In 69 patients, Henneman
t al. (58) used CT to diagnose healed infarcts
hrough LV myocardial hypoenhancement and
emonstrated that CT findings closely correlated to
est SPECT (even though there was a systematic
ias toward underestimation of infarct size by CT).
trial of 34 patients with recent acute MI and 68
ontrol subjects demonstrated that the combination
f a first-pass perfusion deficit and regional wall
otion analysis provided for accurate detection of
I by CT (59).
By echocardiography, the predictive value of
yocardial strain imaging for improvement in car-
iac function after revascularization was evaluated
n 53 patients with ischemic LV dysfunction and
ompared with contrast-enhanced CMR imaging
60) (Fig. 6). Peak systolic radial strain (cutoff of
7%) predicted recovery of function similarly to
MR late enhancement (echocardiography: sensi-
ivity 70%, specificity 85%; CMR: sensitivity 72%,
pecificity 92%).
Another trial assessed the extent of microvascular
amage, evaluated with contrast echocardiography,
n the prediction of LV remodeling in the setting
f acute MI (61). A total of 110 patients with first
eperfused ST-segment elevation MI were evalu-
ted. Multivariate analysis showed that only
hrombolysis In Myocardial Infarction flow grade
3 and the extent of contrast defect (endocardial
ength 25%) were independently associated with
dverse LV remodeling (Fig. 7).
hort-Axis View)
y subject with a homogeneous low signal intensity of the myo-
eperfused inferior infarction. The infarct-related injury is visually
nt extension into the inferior wall of the right ventricle is visibleR (S
ealth
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781rognosis/Risk Stratification
maging receives increasing attention for prognostic
ssessment of patients with known or suspected
AD. Various imaging modalities use imaging of
V function, inducible wall motion abnormalities,
nd perfusion to identify at-risk individuals. Re-
ently, imaging of myocardial scar tissue and even
maging of metabolism have complemented these
pproaches. In addition, CT imaging offers the
ossibility to directly visualize coronary atheroscle-
otic plaque.
Current guidelines do not recommend routine car-
iac stress testing in patients with stable CAD unless
hey report symptoms of angina. Gehi et al. (62)
ompared the prognosis of angina, inducible ischemia
n treadmill stress echocardiography, or both in 937
utpatients with stable CAD. During a mean
ollow-up of 3.9 years, coronary events occurred in 7%
Figure 6. Late-Enhancement Cardiac Magnetic Resonance and E
Contrast-enhanced cardiac magnetic resonance image (left), echoca
(middle), and radial strain tracings (right) for 1 cardiac cycle obtain
tricular dysfunction and akinesia of the septal wall. Contrast-enhanc
tion with more than 50% late gadolinium enhancement. The tracin
a low peak negative systolic radial strain of the septal wall. The seg
gery. Reproduced with permission from Becker et al. (60).
Figure 7. Example of Myocardial Contrast Echocardiography for
(A) Myocardial contrast echocardiography in 4-chamber view in a p
segment elevation myocardial infarction shows a large contrast def
volume. (B) Two-dimensional echocardiogram of the same patient a
with permission from Galiuto et al. (61).f patients without angina or inducible ischemia, in
0% of angina alone, in 21% of inducible ischemia
lone, and in 23% of those with both angina and
nducible ischemia (p  0.001). Although the pres-
nce of angina alone was not associated with events,
he presence of inducible ischemia without self-
eported angina strongly predicted coronary events
hazard ratio: 2.2; p  0.005).
Imaging of impaired myocardial fatty acid metab-
lism by nuclear imaging through beta-Methyl-p-
123I) iodophenyl pentadecanoic acid (BMIPP)
PECT enabled identification of individuals at high
isk for CAD death among 318 dialysis patients
ithout prior MI (63) (Fig. 8). Fifty patients (16%)
ied of cardiac events during a follow-up of 3.6 1.0
ears. Cardiac death was significantly associated with
ighly abnormal BMIPP uptake (summed score of 12
r more; hazard ratio: 21.9) and age of 70 years or
cardiographic Strain Imaging in Transmural Infarction
graphic color-coded short-axis radial strain images at end-systole
rom the same short-axis view in a patient with chronic left ven-
cardiac magnetic resonance imaging indicates transmural infarc-
r the evaluated segments within the circumference demonstrate
t demonstrated no functional recovery after coronary bypass sur-
Assessment of Functional Recovery
nt with left ventricular dysfunction on day 1 after reperfused ST-
n the lateral wall (between arrows) with normal end-diastolic
month follow-up shows an enlarged left ventricle. Reproducedcho
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782lder (hazard ratio: 2.4). When BMIPP uptake (me-
abolism) was assessed in relation to regional thallium
ptake (perfusion), the sensitivity and specificity of
etabolism/perfusion mismatch for predicting cardiac
eath were 86% and 88%, respectively. Event-free
urvival at 3 years was 55% among patients with a
MIPP/thallium mismatch score of 7 or more and
6% in patients with a BMIPP/thallium mismatch
core of below 7. These findings support the assertion
hat altered cardiac metabolism (indicating silent
yocardial ischemia) can identify patients who are at
igh risk for cardiac death. The shift from a predom-
nance of aerobic (fatty acid) to anaerobic (glucose)
etabolism seems to account for a significant portion
f the excessive cardiovascular morbidity and mortality
bserved across all stages of kidney disease (64).
Although the extent and severity of stress-
nduced myocardial ischemia have been well-
ecognized as strong predictors of future CAD
vents (nonfatal MI or death related to MI, heart
ailure, or sudden cardiac death), the prognostic
elevance of resting myocardial perfusion defects in
elation to stress-induced myocardial ischemia has
een incompletely described. Among 7,849 consec-
tive outpatients, time to CAD event (n  545)
as analyzed (65). Among patients without resting
yocardial perfusion defects, overall CAD event
ates were 1.2%, 8%, and 10% for patients with 0%
schemic myocardium, 1% to 4.9% ischemic myo-
ardium, and 5% ischemic myocardium or greater,
espectively (p  0.0001). As the percent myocar-
ium with resting myocardial perfusion defects
Figure 8. Imaging of Myocardial Perfusion and Myocardial Fatty
(A) A 75-year-old woman died of acute myocardial infarction 11 mo
Coronary angiography within 60 days of beta-methyl iodophenyl-pe
left main trunk, right coronary artery, left anterior descending arter
(B) A 74-year-old man died of congestive heart failure 31 months a
50% within 60 days of SPECT. (C) A 61-year-old man died of sudd
not ﬁnd signiﬁcant stenosis within 60 days of SPECT. Reproduced worsened, overall CAD event rates increased, such that for patients with 10% or more of the rest
yocardium with perfusion defects, cardiovascular
eath or MI rates ranged from 7% to 44% (p 
.0001). For every 1% increase in ischemic myocar-
ium, there was a 7% increased risk of CAD events
p  0.0001). A 3% increase in risk of CAD events
as observed for patients with every 1% of the
yocardium with resting defects (p  0.0001).
CMR also allows imaging of both ischemia (per-
usion) and scar. In a study of 218 patients with
uspected CAD, a normal adenosine stress CMR with
n absence of LGE predicted a 99% survival free of
ajor adverse cardiac events over 12 months, suggest-
ng the excellent negative predictive value of this
iagnostic test (66). Infarct size as assessed by mag-
etic resonance late enhancement was shown to be the
ost powerful predictor of adverse outcomes in a study
f 122 patients after ST-segment elevation MI (67). In a
rial of 187 diabetic individuals, 109 of whom had no
nown prior MI, the presence of late enhancement
redicted a 4-fold incidence of major adverse cardiac
vents compared with those without LGE (68).
CT relies on direct visualization of plaque for risk
ssessment. Some data have become available as to
he prognostic implications of plaque seen in coro-
ary CTA. Min et al. (69) demonstrated in 1,127
ymptomatic patients studied by contrast-enhanced
6-slice CT that the presence of plaque in more
han 5 coronary segments was associated with a
ignificantly increased mortality rate over a mean
ollow-up period of 15 months. Shaw et al. (70)
emonstrated that the prognostic information ob-
ids in Dialysis Patients Who Died of Cardiac Events
s after single-photon emission computed tomography (SPECT).
decanoic acid (BMIPP) SPECT revealed signiﬁcant stenoses in the
d left circumﬂex artery. The patient refused invasive therapy.
SPECT. Coronary angiography did not ﬁnd signiﬁcant stenosis of
cardiac events 38 months after SPECT. Coronary angiography did
permission from Nishimura et al. (63). TI  thallium.Ac
nth
nta
y, an
fter
enained by CTA is similar to that of SPECT
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783yocardial perfusion imaging. Another group pro-
ided long-term (up to 12 years) follow-up data of
,538 patients studied by contrast-enhanced elec-
ron beam tomography. They demonstrated that
he presence of obstructive plaque in 1 or more
essels and of nonobstructive plaque in 3 coronary
essels was associated with a significantly increased
ortality (whereas the presence of nonobstructive
laque in only 1 or 2 vessels was not) (71). A group
rom Korea followed 1,000 asymptomatic male,
iddle-aged individuals for over 17 months and,
ecause plaque and stenoses were not associated
ith remote coronary events, concluded that their
tudy failed to demonstrate a prognostic benefit of
oronary CTA for “screening” purposes (72).
Results of the MESA (Multi-Ethnic Study of
therosclerosis) trial, published in March 2008, con-
rmed the prognostic value of coronary artery calcium
CAC) in asymptomatic individuals: in a population-
ased sample of 6,722 individuals, adding calcium
core to standard risk factors significantly increased
he area under the receiver-operator characteristic
urve for prediction of coronary events (0.77 for risk
actors alone vs. 0.82 for risk factors plus coronary
alcium, p  0.0001) (73). In another analysis of the
ame population, each 1-SD increase of the coronary
alcium score was associated with a 2.1-fold hazard
atio for coronary events, whereas each 1-SD increase
n intima media thickness was associated with an only
.3-fold hazard ratio (74).
The incremental prognostic value of CAC over
yocardial perfusion was assessed in 695 consecu-
ive patients with intermediate-risk for CAD who
nderwent rest-stress rubidium 82 PET on a hybrid
ET-CT scanner (75). Risk-adjusted survival anal-
sis demonstrated a stepwise increase in event rates
death and MI) with increasing CAC scores in
atients with and without ischemia on PET myo-
ardial perfusion imaging. Among patients with
ormal PET myocardial perfusion imaging, the
nnualized event rate in patients with no CAC was
ower than in those with a CAC score 1,000
2.6% and 12.3%, respectively). Likewise, in pa-
ients with ischemia on PET myocardial perfusionmal model of ischemia-reperfusion.
J Am Coll Cardiol 2008;51:651–9.
ischemic condition
diol 2008;51:149 –AC was lower than among patients with a CAC
core1,000 (8.2% and 22.1%, respectively). These
ndings suggest that, independent of the presence
f ischemia in PET myocardial perfusion imaging,
ncreasing coronary calcium scores are associated
ith a stepwise increase of the risk of future adverse
vents.
ew Guidelines and Statements
everal new statements, guidelines, and recommen-
ations that address issues relevant to the noninva-
ive imaging of CAD have been published.
The ACCF/ASE/ACEP/AHA/ASNC/
CAI/SCCT/SCMR 2008 appropriateness crite-
ia for stress echocardiography provide a detailed
ist of indications for stress echocardiography in
arious clinical situations (76). A consensus state-
ent of the American Society of Echocardiogra-
hy on the clinical applications of ultrasonic
ontrast agents details the appropriate clinical use
f these agents (77). For CMR, protocols for
erforming CMR were published to aid in stan-
ardizing image acquisition across vendors and
nstitutions (78). A Scientific Statement of the
merican Heart Association on noninvasive cor-
nary artery imaging summarizes available data
nd discusses potential indications of coronary
rtery visualization by magnetic resonance and
T (79). A report of the American College of
ardiology Foundation/American Heart Associ-
tion and American College of Physicians Task
orce on Clinical Competence and Training,
ndorsed by numerous professional societies, out-
ines suggested training requirements for multi-
odality, noninvasive cardiovascular imaging
80). Finally, 2 statements provide a framework
nd key data elements for reporting of cardiovas-
ular imaging studies (81,82).
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